Related Experiment Video

Updated: Aug 11, 2026

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
03:53

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on: April 19, 2024

Etiology of CF: knowns and unknowns

J R Riordan1

  • 1Department of Research, Mayo Clinic Scottsdale, Arizona 85259, USA.

Pediatric Pulmonology. Supplement
|March 27, 1999
PubMed

Insights

Understanding cystic fibrosis (CF) requires exploring beyond the primary chloride channel function of the CFTR protein. Further research is needed to uncover additional CFTR roles and fully explain CF's complex molecular pathophysiology.

Area of Science:

  • Biochemistry
  • Genetics
  • Molecular Biology

Background:

  • Cystic Fibrosis (CF) presents complex clinical features that are not fully explained by the known function of the Cystic Fibrosis Transmembrane conductance Regulator (CFTR) protein.
  • The single, well-established function of CFTR as a chloride channel does not adequately rationalize all observed aspects of CF pathophysiology.

Purpose of the Study:

  • To investigate potential undiscovered functions of the CFTR protein.
  • To elucidate the molecular mechanisms linking primary CFTR dysfunction to diverse pathological processes in CF.

Main Methods:

  • This study proposes a conceptual framework for future research rather than presenting experimental results.
  • It emphasizes the need for detailed molecular investigations into the CFTR protein's functions and downstream effects.

Main Results:

  • The current understanding of CFTR's role is insufficient to explain the full spectrum of CF features.
  • A gap exists in fully connecting the primary defect (chloride channel dysfunction) to the resulting pathologies.

Conclusions:

  • Resolving the complexities of CF requires either discovering novel functions of CFTR or thoroughly mapping the intermediate steps between chloride channel malfunction and disease manifestations.
  • Further research into CFTR's multifaceted roles is crucial for advancing our understanding and treatment of cystic fibrosis.

More Related Videos

Cystic Fibrosis Aggregate Biofilm Model to Study Infection-relevant Gene Expression08:58

Cystic Fibrosis Aggregate Biofilm Model to Study Infection-relevant Gene Expression

Published on: April 18, 2025

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

Related Concept Videos

Factors Affecting Illness01:18

Factors Affecting Illness

When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness, disability,...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...